AEBSF HCl structure
|
Common Name | AEBSF HCl | ||
---|---|---|---|---|
CAS Number | 30827-99-7 | Molecular Weight | 239.695 | |
Density | N/A | Boiling Point | 292.5ºC at 760 mmHg | |
Molecular Formula | C8H11ClFNO2S | Melting Point | 175-177 °C | |
MSDS | Chinese USA | Flash Point | 130.7ºC | |
Symbol |
GHS05 |
Signal Word | Danger |
Use of AEBSF HClAEBSF is an irreversible inhibitor of serine proteases, such as chymotrypsin, kallikrein, plasmin, thrombin, and trypsin. |
Name | 4-(2-aminoethyl)benzenesulfonyl fluoride,hydrochloride |
---|---|
Synonym | More Synonyms |
Description | AEBSF is an irreversible inhibitor of serine proteases, such as chymotrypsin, kallikrein, plasmin, thrombin, and trypsin. |
---|---|
Related Catalog | |
In Vitro | AEBSF inhibits the constitutive production of Aβ by directly inhibiting β-secretase in five different human cell lines, both neural and nonneural[1]. AEBSF, as a serine protease inhibitor, inhibits the lysis of leukemic cells by human macrophages without inhibiting macrophage secretion of TNF-α and IL-1β[2]. AEBSF also disturbs the growth of blastocysts on endometrial cells and inhibit the adhesion of HeLa cells on HUVECs by altering the protein secretion pattern[4]. |
In Vivo | AEBSF (76.8 mg/kg daily, i.p.) results in prolongation of the survival of mice that have been given a lethal T. gondii infection[3]. AEBSF also reduces airway response and underlying inflammation in cockroach allergen-induced murine model[4]. |
Cell Assay | The HeLa cells suspended in RPMI-1640 media containing 10% FCS are plated into each well of a 96-well microplate (5×103 cells/200 μL/well). After incubation for 24 h at 37°C, cells are treated with different doses of AEBSF (0, 25, 50, 100 μg/mL) for 48 h. Then, 20 μL fresh 3-(4,5)-dimethylthiahiazo (-z-y1)-3,5-diphenytetrazoliumromide (MTT) reagent (5 μg/μL) is added into each well, and cells are cultured at 37°C in 5% CO2 for another 4 h. The media are discarded carefully, and 150 μL DMSO is added. Absorbance is read on a microplate reader at dual wavelengths of 540 and 620 nm. |
Animal Admin | Mice injected with 2.5×103 parasites are randomLy assigned to one of the treatment groups according to the treatment given: without drugs (control group), vehicle alone (vehicle control group), pyrimethamine alone at different doses, LY311727 alone at different doses, AEBSF alone at different doses or AEBSF 76.8 mg/kg plus pyrimethamine 10 mg/kg. Each treatment group consists of 10 animals. Treatment is initiated 24 h after parasite inoculation and is continued for seven consecutive days. Mouse survival is monitored daily and continued in live mice until 15 days post-infection. All experiments are performed three times and the data shown represent the cumulative results. |
References |
Boiling Point | 292.5ºC at 760 mmHg |
---|---|
Melting Point | 175-177 °C |
Molecular Formula | C8H11ClFNO2S |
Molecular Weight | 239.695 |
Flash Point | 130.7ºC |
Exact Mass | 239.018311 |
PSA | 68.54000 |
LogP | 3.42910 |
Storage condition | 0-6°C |
Water Solubility | 10 g/L (20 ºC) |
Symbol |
GHS05 |
---|---|
Signal Word | Danger |
Hazard Statements | H314 |
Precautionary Statements | P280-P303 + P361 + P353-P304 + P340 + P310-P305 + P351 + P338 |
Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
Hazard Codes | C:Corrosive; |
Risk Phrases | R34 |
Safety Phrases | S45-S36/37/39-S26 |
RIDADR | UN 3261 |
Packaging Group | II |
Hazard Class | 8 |
HS Code | 2921499090 |
HS Code | 2921499090 |
---|---|
Summary | 2921499090 other aromatic monoamines and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
Detailed characterization of a long-term rodent model of critical illness and recovery.
Crit. Care Med. 43(3) , e84-96, (2015) To characterize a long-term model of recovery from critical illness, with particular emphasis on cardiorespiratory, metabolic, and muscle function.Randomized controlled animal study.University researc... |
|
Hook proteins: association with Alzheimer pathology and regulatory role of hook3 in amyloid beta generation.
PLoS ONE 10(3) , e0119423, (2015) Defects in intracellular transport are implicated in the pathogenesis of Alzheimer's disease (AD). Hook proteins are a family of cytoplasmic linker proteins that participate in endosomal transport. In... |
|
Protective effect of Ferula gummosa hydroalcoholic extract against nitric oxide deficiency-induced oxidative stress and inflammation in rats renal tissues.
Clin. Exp. Hypertens. 37(2) , 136-41, (2015) Nitric oxide (NO) synthase inhibition increases hypertension and causes renal injury. Ferula gummosa is used in Iranian traditional medicine for treatment of several diseases and has been reported to ... |
4-(2-Aminoethyl)benzene-1-sulfonyl fluoride hydrochloride |
Benzenesulfonyl fluoride, 4-(2-aminoethyl)-, hydrochloride (1:1) |
4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride |
2-[4-(fluorosulfonyl)phenyl]ethanaminium chloride |
AEBSF |
AEBSF hydrochloride |
4-(2-Aminoethyl)benzenesulphonyl fluoride hydrochloride |
4-(2-Aminoethyl)benzenesulfonyl fluoride, hydrochloride |
MFCD00132962 |
Pefabloc SC |
4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride (1:1) |
Benzenesulfonyl fluoride hydrochloride, 4-(2-aminoethyl)- |
4-(2-Aminoethyl)-benzenesulfonylfluoride hydrochloride |
AEBSF HCl |